The purpose of this research study is to find out if obstructive sleep apnea plays a role
in the ability of antifibrotic medications to work well. We are doing this research
because people with IPF have a higher rate of OSA and are often undiagnosed. By
understanding the role OSA plays in the effectiveness of antifibrotic medications, we will
be able to offer more effective treatment for patients with IPF in the future.
This study is being done at the University of Wisconsin-Madison (UW-Madison) and the
William S. Middleton Memorial VA Hospital. A total of about 45 people will participate in
this study.
Funding for this study is provided by Boehringer Ingelheim.